The RenTg Mice: A Powerful Tool to Study Renin-Dependent Chronic Kidney Disease

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Huby, Anne Cecile ^a   Kavvadas, Panagiotis ^a   Alfieri, Carlo ^a   Abed, Ahmed ^a   Toubas, Julie ^a   Rastaldi, Maria Pia ^b   Dussaule, Jean Claude ^a,c,d   Chatziantoniou, Christos ^a,d   Chadjichristos, Christos E ^a,d  

^a INSERM   (France)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c HÔPITAL SAINT ANTOINE   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; KIDNEY INJURY MOLECULE 1; NEPHRIN; RENIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL INVASION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GLOMERULOSCLEROSIS; GLOMERULUS; HETEROZYGOSITY; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY HYPERTROPHY; KIDNEY ISCHEMIA; LEUKOCYTE; MACROPHAGE; MOUSE; MOUSE STRAIN; NEPHROSCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; BIOLOGICAL MARKERS; CELL ADHESION; DISEASE PROGRESSION; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, TRANSGENIC; PODOCYTES; RENAL INSUFFICIENCY, CHRONIC; RENIN;

MUS;

EID: 84871576753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052362     Document Type: Article

References (25)

1. Dirks JRG, Horton S, Schieppati A, Rivzi SAH (2006) Diseases of the kidney and the urinary system. In: Disease control priorities in developing countries. New York: Oxford University Press and the World Bank: 695-706.
2. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, et al. (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med. 361: 40-51.
3. Dussaule JC, Chatziantoniou C, (2007) Reversal of renal disease: is it enough to inhibit the action of angiotensin II? Cell Death Differ. 14: 1343-9.
4. Fakhouri F, Placier S, Ardaillou R, Dussaule JC, Chatziantoniou C, (2001) Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta. J Am Soc Nephrol 12: 2701-10.
5. Ying L, Flamant M, Vandermeersch S, Boffa JJ, Chatziantoniou C, et al. (2003) Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats. Hypertension 42: 937-44.
6. Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, et al. (2003) Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 14: 1132-44.
7. Placier S, Boffa JJ, Dussaule JC, Chatziantoniou C, (2006) Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice. Nephrol Dial Transplant 21: 881-8.
8. Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, et al. (2008) Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol 173: 631-42.
9. Huby AC, Rastaldi MP, Caron K, Smithies O, Dussaule JC, et al. (2009) Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS One. 4: e6721.
10. Caron KM, James LR, Kim HS, Morham SG, Sequeira Lopez ML, et al. (2002) A genetically clamped renin transgene for the induction of hypertension. Proc Natl Acad Sci U S A. 99: 8248-52.
11. Chatziantoniou C, Dussaule JC, (2008) Is kidney injury a reversible process? Curr Opin Nephrol Hypertens. 17: 76-81.
12. Macconi D, (2010) Targeting the renin angiotensin system for remission/regression of chronic kidney disease. Histol Histopathol. 25: 655-68.
13. Sata M, Fukuda D, (2010) Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest. 57: 12-25.
14. Diamond JR, Anderson S, (1990) Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition. Am J Pathol 137: 1323-32.
15. Eliahou H, Avinoach I, Shahmurov M, Ben-David A, Shahar C, et al. (2001) Renoprotective effect of angiotensin II receptor antagonists in experimental chronic renal failure. Am J Nephrol 21: 78-83.
16. Navarro-Cid J, Maeso R, Rodrigo E, Munoz-Garci{dotless}a R, Ruilope LM, et al. (1996) Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens 9: 1077-83.
17. Hernández-Presa M, Bustos C, Ortego M, Tuñon J, Renedo G, et al. (1997) Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95: 1532-41.
18. Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, et al. (1999) Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 100: 1646-52.
19. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, et al. (2000) Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol. 20: 645-51.
20. Boffa JJ, Tharaux PL, Placier S, Ardaillou R, Dussaule JC, et al. (1999) Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism. Circulation 100: 1901-8.
21. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, et al. (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 9: 964-8.
22. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, et al. (2003) Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol. 285: F1060-7.
23. Yanagita M, Okuda T, Endo S, Tanaka M, Takahashi K, et al. (2006) Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest. 116: 70-9.
24. Yanagita M, (2006) Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int. 70: 989-93.
25. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, et al. (2003) Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol. 286: F590-F596.